Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044
Go back to Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.92 -0.04 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.96 | 52 Week High | $1.37 | |||
| Open | $0.99 | 52 Week Low | $0.24 | |||
| Day High | $1.02 | P/E | N/A | |||
| Day Low | $0.91 | EPS | $0.00 | |||
| Volume | 1,035,930 | |||||
